Aditxt

Aditxt Debt / Assets

The Debt-to-Assets Ratio of Aditxt (ADTX) as of Nov 5, 2026 is 0.18. In the previous year, Debt-to-Assets Ratio was 0.22 — a change of -15.45% (lower).

Debt / Assets

0.18

YoY

-15.45%

Last updated:

Debt-to-Assets Ratio of Aditxt is 2025 0.18 . Debt-to-Assets Ratio of Aditxt was 2024 0.22 . It decreases by -15.45% lower compared to the previous year.

The Aditxt Debt / Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Debt / Assets
Date
Debt / Assets
Jan 1, 2018
1.41 USD
Jan 1, 2019
1.34 USD
Jan 1, 2020
0.14 USD
Jan 1, 2021
0.28 USD
Jan 1, 2022
0.32 USD
Jan 1, 2023
0.41 USD
Jan 1, 2024
0.22 USD
Jan 1, 2025
0.18 USD
The Aditxt Debt / Assets history
YEARDebt / AssetsYoY
0.18-15.45%
0.22-47.32%
0.41+29.73%
0.32+11.18%
0.28+102.01%
0.14-89.54%
1.34-5.19%
1.41—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Aditxt Stock analysis

What does Aditxt do? ADiTx Therapeutics, Inc. develops nucleic acid-based technologies for organ transplant tolerance and immune system health. The company's Apoptotic DNA Immunotherapy (ADi) reprograms the immune system to induce tolerance, while Aditxt Immune Monitor (AiM) provides personalized immune profiles. Both technologies are in preclinical development, with the firm focusing on minimizing transplant rejection and addressing autoimmune diseases and allergies. The company is headquartered in Mountain View, California and employs 2 full-time staff. ADiTx Therapeutics, Inc. generates revenue through the development and potential future commercialization of its immune reprogramming and monitoring technologies. The company is a preclinical stage life sciences entity targeting medical applications in organ transplantation and immune-related conditions. Its core products, ADi and AiM, are designed to address unmet medical needs in immune system management. The firm's focus on immune reprogramming and monitoring positions it for potential partnerships with healthcare providers and biopharmaceutical companies in the future. Aditxt is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Aditxt stock

Debt-to-Assets Ratio of Aditxt is 0.18 in 2025.

Debt-to-Assets Ratio of Aditxt changed from 0.22 to 0.18, representing a -15.45% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Debt-to-Assets Ratio Aditxt since 2006 – with annual values, charts, and detailed analysis.

The Debt-to-Assets ratio measures what percentage of a company's assets are financed through debt. Higher ratios indicate greater financial risk.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Debt-to-Assets Ratio's Aditxt with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Aditxt

All Key Metrics — Aditxt